Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation

Molecular and Cellular Endocrinology

Volumn 285, Issue 1-2, 2008, Pages 43-50

  Ogunwobi, Olorunseun O ^a   Beales, Ian L P ^a,b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adiponectin; AMP activated kinase; Cell proliferation; Leptin; Obesity; Oesophageal adenocarcinoma; Phosphoprotein phosphatase

Indexed keywords

ADENOSINE PHOSPHATE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; LEPTIN; OKADAIC ACID; PROTEIN KINASE B; SERINE; SMALL INTERFERING RNA; THREONINE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ADENOCARCINOMA; ADIPONECTIN; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITORS; ESOPHAGEAL NEOPLASMS; HUMANS; LEPTIN; MULTIENZYME COMPLEXES; OBESITY; OKADAIC ACID; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZOLES; PYRIMIDINES; RATS; RECEPTORS, ADIPONECTIN; RNA INTERFERENCE;

EID: 39849087832     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.01.023     Document Type: Article

References (39)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
2. Attoub S., Noe V., Pirola L., Bruyneel E., Chastre E., Mareel M., Wymann M.P., and Gespach C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J. 14 (2000) 2329-2338
3. Baratta M. Leptin-from a signal of adiposity to a hormonal mediator in peripheral tissues. Med. Sci. Monit. 8 (2002) RA282-RA292
4. Beales I.L., Ogunwobi O.O., Cameron E., El-Amin K., Mutungi G., and Wilkinson M. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a functional and immunohistochemical study. BMC Cancer 7 (2007) 97
5. Beales I.L., and Ogunwobi O. Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways. Mol. Cell Endocrinol. 247 (2006) 140-149
6. Beales I.L., and Ogunwobi O.O. Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture. Mol. Cell Endocrinol. 274 (2007) 60-68
7. Calle E.E., and Thun M.J. Obesity and cancer. Oncogene 23 (2004) 6363-6378
8. Caminos J.E., Nogueiras R., Gallego R., Bravo S., Tovar S., Garcia-Caballero T., Casanueva F.F., and Dieguez C. Expression and regulation of adiponectin and receptor in human and rat placenta. J. Clin. Endocrinol. Metab. 90 (2005) 4276-4286
9. Combs T.P., Pajvani U.B., Berg A.H., Lin Y., Jelicks L.A., Laplante M., Nawrocki A.R., Rajala M.W., Parlow A.F., Cheeseboro L., Ding Y.Y., Russell R.G., Lindemann D., Hartley A., Baker G.R., Obici S., Deshaies Y., Ludgate M., Rossetti L., and Scherer P.E. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145 (2004) 367-383
10. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L., and Caro J.F. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334 (1996) 292-295
11. Dal Maso L., Augustin L.S., Karalis A., Talamini R., Franceschi S., Trichopoulos D., Mantzoros C.S., and La Vecchia C. Circulating adiponectin and endometrial cancer risk. J. Clin. Endocrinol. Metab. 89 (2004) 1160-1163
12. Dieudonne M.N., Bussiere M., Dos Santos E., Leneveu M.C., Giudicelli Y., and Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 345 (2006) 271-279
13. Fam B.C., Morris M.J., Hansen M.J., Kebede M., Andrikopoulos S., Proietto J., and Thorburn A.W. Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity. Diabetes Obes. Metab. 9 (2007) 840-852
14. Fitzgerald R.C., Omary M.B., and Triadafilopoulos G. Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J. Cell Sci. 110 (1997) 663-671
15. Frankenberry K.A., Somasundar P., McFadden D.W., and Vona-Davis L.C. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am. J. Surg. 188 (2004) 560-565
16. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
17. Hardie D.G. The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell Sci. 117 (2004) 5479-5487
18. Hardwick J.C., van Den Brink G.R., Offerhaus G.J., van Deventer S.J., and Peppelenbosch M.P. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121 (2001) 79-90
19. Haugen F., and Drevon C.A. Activation of nuclear factor-{kappa}B by high molecular weight and globular adiponectin. Endocrinology 148 (2007) 5478-5486
20. Ishikawa M., Kitayama J., Kazama S., Hiramatsu T., Hatano K., and Nagawa H. Plasma adiponectin and gastric cancer. Clin. Cancer Res. 11 (2005) 466-472
21. Ishikawa M., Kitayama J., Yamauchi T., Kadowaki T., Maki T., Miyato H., Yamashita H., and Nagawa H. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci. 98 (2007) 1120-1127
22. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 26 (2005) 439-451
23. King T.D., Song L., and Jope R.S. AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. Biochem. Pharmacol. 71 (2006) 1637-1647
24. Lagergren J., Bergstrom R., and Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann. Intern. Med. 130 (1999) 883-890
25. Mahidhara R.S., Queiroz De Oliveira P.E., Kohout J., Beer D.G., Lin J., Watkins S.C., Robbins P.D., and Hughes S.J. Altered trafficking of Fas and subsequent resistance to Fas-mediated apoptosis occurs by a wild-type p53 independent mechanism in esophageal adenocarcinoma. J. Surg. Res. 123 (2005) 302-311
26. Oana F., Takeda H., Matsuzawa A., Akahane S., Isaji M., and Akahane M. Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a beta3-adrenoceptor agonist. Eur. J. Pharmacol. 518 (2005) 71-76
27. Ogunwobi O., Mutungi G., and Beales I.L. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147 (2006) 4505-4516
28. Ogunwobi O.O., and Beales I.L. The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int. J. Colorectal. Dis. 22 (2007) 401-409
29. Ogunwobi O.O., and Beales I.L.P. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul. Peptides 134 (2006) 105-113
30. Pajvani U.B., Du X., Combs T.P., Berg A.H., Rajala M.W., Schulthess T., Engel J., Brownlee M., and Scherer P.E. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem. 278 (2003) 9073-9085
31. Petridou E., Belechri M., Dessypris N., Koukoulomatis P., Diakomanolis E., Spanos E., and Trichopoulos D. Leptin and body mass index in relation to endometrial cancer risk. Ann. Nutr. Metab. 46 (2002) 147-151
32. Somasundar P., Yu A.K., Vona-Davis L., and McFadden D.W. Differential effects of leptin on cancer in vitro. J. Surg. Res. 113 (2003) 50-55
33. Stattin P., Lukanova A., Biessy C., Soderberg S., Palmqvist R., Kaaks R., Olsson T., and Jellum E. Obesity and colon cancer: does leptin provide a link?. Int. J. Cancer 109 (2004) 149-152
34. Tartaglia L.A. The leptin receptor. J. Biol. Chem. 272 (1997) 6093-6096
35. Todisco A., Seva C., Takeuchi Y., Dickinson C.J., and Yamada T. Somatostatin inhibits AP-1 function via multiple protein phosphatases. Am. J. Physiol. 269 (1995) G160-G166
36. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., Hara K., Hada Y., Vasseur F., Froguel P., Kimura S., Nagai R., and Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278 (2003) 40352-40363
37. Waki H., Yamauchi T., Kamon J., Kita S., Ito Y., Hada Y., Uchida S., Tsuchida A., Takekawa S., and Kadowaki T. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146 (2006) 790-796
38. Wilsey J., Zolotukhin S., Prima V., and Scarpace P.J. Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R1011-R1020
39. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., and Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769